Netherlands· NL-7428d2c90929

Edoxaban Cipla 60 mg, filmomhulde tabletten

A edoxaban product containing edoxabantosilaat 1-water, registered in Netherlands by Cipla Europe N.V.. The same ATC class is registered in 17 of our 19 countries.

ATC B01AF03

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about edoxabantosilaat 1-waterAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Edoxaban is registered in 17 of 19 countries.

Countries holding a registration under ATC B01AF03 (edoxaban), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
10 of them publish a price we can compare per daily dose

Search edoxaban products by name

Edoxaban · ATC B01AF03

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of edoxaban costs, country by country.

Normalised to the WHO defined daily dose (60 mg), so markets compare like for like.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Edoxaban · price per daily dose (60 mg)

USD · FX 28 Sept 2026

IT Italy$7.87
CH Switzerland$6.81

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: EDOXABANTOSILAAT 1-WATER
Manufacturer: Cipla Europe N.V.
Country: Netherlands (NL)
ATC code: B01AF03
ATC class: Edoxaban
Defined daily dose: 60 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
134530

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

262 interactions on record for edoxaban.

Graded by severity as the source publishes them — 182 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check edoxaban against other medicines How interaction checks work

Edoxaban · interactions on record

262 records

182 severe
80 moderate

Most severe, free to view

RolapitantA04AD14severe
EliglustatA16AX10severe
DicoumarolB01AA01severe
WarfarinB01AA03severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Edoxaban in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All edoxaban products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Edoflusio, Edoxaban !@ctavis
Belgium · Edoxaban Hcs, Edoxaban Sandoz
Bulgaria · Edoflusio, Делианда
Czechia · Delianda, Edoxaban +pharma
Germany · Edoxaban 1 A Pharma, Edoxaban 123 Acurae Pharma
Denmark · Arelzamio, Dijuga
Estonia · Delianda, Edoflusio
Spain · Edoxabán Almus, Edoxabán Cinfa
Finland · Edoxaban Avansor, Edoxaban Krka
France · Oblonela
United Kingdom (Northern Ireland) · Edoxaban, Edoxaban Accord
Greece · Delianda, Edoxaban Pharmapath
Croatia · Cagluen, Delianda
Hungary · Cagluen, Delianda
Ireland · Edoxaban Accord, Edoxaban Krka
Iceland · Edoxaban Accord, Edoxaban Krka
Italy · Edoxaban Dr. Reddy’s, Edoxaban Hcs
Liechtenstein · Lixiana, Roteas
Lithuania · Delianda, Edoflusio
Luxembourg · Oblonela
Latvia · Delianda, Edoflusio
Malta · Arelzamio, Dijuga
Norway · Edoxaban Krka, Edoxaban Sandoz
Poland · Delianda, Edoflusio
Portugal · Edoxabano Bluepharma, Edoxabano Kern Pharma
Romania · Cagluen, Delianda
Sweden · Edoflusio, Edoxaban Avansor
Slovenia · Delianda, Edoflusio
Slovakia · Delianda, Edoxaban Accord

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/346cb7da-a294-480b-8a3c-2a512db504e8
GET /v1/drugs/346cb7da-a294-480b-8a3c-2a512db504e8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h134530_smpc_en.pdf",
  "strength": null,
  "atc_label": "Edoxaban",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg134530",
  "excipients": [
    "COPOLYMEER VAN MACROGOL (25,0)-POLY(VINYL ALCOHOL) (75,0) (E 1209)",
    "COPOVIDON (E 1208)",
    "CROSPOVIDON (E 1202)",
    "HYPROLOSE (E 463)",
    "IJZEROXIDE GEEL (E 172)",
    "KAOLIEN (E 559)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MANNITOL (D-) (E 421)",
    "NATRIUMLAURILSULFAAT",
    "SILICIUMDIOXIDE (E 551)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "EDOXABANTOSILAAT 1-WATER"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h134530_piluk.pdf",
  "authorised_at": "2025/12/18",
  "procedure_number": "NL/H/6298/003",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "134530",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about edoxaban.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console